AllianceBernstein’s Tvardi Therapeutics TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,426
| Closed | -$79.5K | – | 3312 |
|
|
2024
Q1 | $79.5K | Hold |
2,426
| – | – | ﹤0.01% | 3047 |
|
|
2023
Q4 | $64.9K | Sell |
2,426
-163
| -6% | -$6.75K | ﹤0.01% | 3110 |
|
|
2023
Q3 | $157K | Hold |
2,589
| – | – | ﹤0.01% | 3010 |
|
|
2023
Q2 | $264K | Buy |
2,589
+1,272
| +97% | +$175K | ﹤0.01% | 2907 |
|
|
2023
Q1 | $233K | Sell |
1,317
-185
| -12% | -$62K | ﹤0.01% | 2864 |
|
|
2022
Q4 | $581K | Buy |
1,502
+101
| +7% | +$38.4K | ﹤0.01% | 2549 |
|
|
2022
Q3 | $472K | Buy |
1,401
+138
| +11% | +$50K | ﹤0.01% | 2678 |
|
|
2022
Q2 | $415K | Buy |
1,263
+4
| +0.3% | +$1.4K | ﹤0.01% | 2758 |
|
|
2022
Q1 | $551K | Buy |
1,259
+3
| +0.2% | +$1.23K | ﹤0.01% | 2635 |
|
|
2021
Q4 | $551K | Sell |
1,256
-270
| -18% | -$136K | ﹤0.01% | 2693 |
|
|
2021
Q3 | $849K | Sell |
1,526
-60
| -4% | -$30.1K | ﹤0.01% | 2555 |
|
|
2021
Q2 | $815K | Buy |
1,586
+225
| +17% | +$143K | ﹤0.01% | 2620 |
|
|
2021
Q1 | $1.06M | Hold |
1,361
| – | – | ﹤0.01% | 2385 |
|
|
2020
Q4 | $741K | Sell |
1,361
-353
| -21% | -$185K | ﹤0.01% | 2418 |
|
|
2020
Q3 | $785K | Sell |
1,714
-50
| -3% | -$29K | ﹤0.01% | 2295 |
|
|
2020
Q2 | $1.09M | Buy |
1,764
+497
| +39% | +$274K | ﹤0.01% | 2166 |
|
|
2020
Q1 | $602K | Hold |
1,267
| – | – | ﹤0.01% | 2254 |
|
|
2019
Q4 | $735K | Buy |
1,267
+59
| +5% | +$41.4K | ﹤0.01% | 2405 |
|
|
2019
Q3 | $795K | Hold |
1,208
| – | – | ﹤0.01% | 2345 |
|
|
2019
Q2 | $935K | Sell |
1,208
-2,233
| -65% | -$1.57M | ﹤0.01% | 2339 |
|
|
2019
Q1 | $2.43M | Sell |
3,441
-162
| -4% | -$97K | ﹤0.01% | 1790 |
|
|
2018
Q4 | $1.69M | Buy |
3,603
+2,389
| +197% | +$1.54M | ﹤0.01% | 1929 |
|
|
2018
Q3 | $1.05M | Sell |
1,214
-103
| -8% | -$74.4K | ﹤0.01% | 2311 |
|
|
2018
Q2 | $908K | Sell |
1,317
-175
| -12% | -$89K | ﹤0.01% | 2361 |
|
|
2018
Q1 | $665K | Buy |
1,492
+420
| +39% | +$204K | ﹤0.01% | 2433 |
|
|
2017
Q4 | $472K | Hold |
1,072
| – | – | ﹤0.01% | 2552 |
|
|
2017
Q3 | $528K | Hold |
1,072
| – | – | ﹤0.01% | 2547 |
|
|
2017
Q2 | $594K | Buy |
1,072
+508
| +90% | +$322K | ﹤0.01% | 2545 |
|
|
2017
Q1 | $373K | Hold |
564
| – | – | ﹤0.01% | 2625 |
|
|
2016
Q4 | $189K | Hold |
564
| – | – | ﹤0.01% | 2904 |
|
|
2016
Q3 | $170K | Hold |
564
| – | – | ﹤0.01% | 2875 |
|
|
2016
Q2 | $98K | Buy |
+564
| New | +$123K | ﹤0.01% | 2914 |
|
|
2016
Q1 | – | Sell |
-317
| Closed | -$192K | – | 2934 |
|
|
2015
Q4 | $192K | Buy |
+317
| New | +$174K | ﹤0.01% | 2758 |
|
|
2015
Q2 | – | Sell |
-17
| Closed | -$6K | – | 3289 |
|
|
2015
Q1 | $6K | Hold |
17
| – | – | ﹤0.01% | 3407 |
|
|
2014
Q4 | $6K | Hold |
17
| – | – | ﹤0.01% | 3358 |
|
|
2014
Q3 | $5K | Sell |
17
-16
| -48% | -$6.57K | ﹤0.01% | 3357 |
|
|
2014
Q2 | $20K | Buy |
+33
| New | +$17.8K | ﹤0.01% | 3233 |
|
Other funds holding TVRD
DGI
C
FCM
AllianceBernstein's TVRD Position: Q2 2024 in Review
AllianceBernstein sold out of Tvardi Therapeutics (TVRD) in Q2 2024, closing a stake of 2,426 shares — an estimated $79.5K sold.
AllianceBernstein first reported a position in TVRD in Q2 2014 and held it in 37 quarters. The position peaked at $2.43M in Q1 2019. 79 funds tracked by Wall St. Rank hold TVRD as of Q2 2024.
- AllianceBernstein reported no remaining Tvardi Therapeutics position as of Q2 2024 after selling out during the quarter.
- AllianceBernstein sold 2,426 Tvardi Therapeutics shares in Q2 2024, an estimated $79.5K.
- AllianceBernstein first reported a position in Tvardi Therapeutics in Q2 2014 and held it in 37 quarters.
- AllianceBernstein's Tvardi Therapeutics position peaked at $2.43M in Q1 2019.
- 79 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q2 2024.
Based on AllianceBernstein's 13F filing for Q2 2024, filed 14 Aug 2024.